Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 1.73x is 20% above its 5-year average of 1.45x, near the high end of its 5-year range (-143.69x–5.15x).
10.87% below its 12-month average of 1.94x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2027 (2026-06-30): 2.98x.
INTEREST COVERAGE RATIO
1.73x
INTEREST COVERAGE RATIO AVG TTM
1.94x
INTEREST COVERAGE RATIO AVG 3Y
1.23x
INTEREST COVERAGE RATIO AVG 5Y
1.45x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-10.87%
CURRENT VS 3Y AVG
+41.11%
CURRENT VS 5Y AVG
+19.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
+129.88%
vs the sector median at left
Mesa Laboratories, Inc.
Market Cap
$764.65M
Interest Coverage Ratio
1.73x
TTM Avg
1.94x
3Y Avg
1.23x
5Y Avg
1.45x
Market Cap
$767.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$776.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$752.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$777.34M
Interest Coverage Ratio
-5.87x
TTM Avg
6.84x
3Y Avg
6.84x
5Y Avg
3.53x
Market Cap
$789.07M
Interest Coverage Ratio
-1.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$790.46M
Interest Coverage Ratio
N/A
TTM Avg
85.72x
3Y Avg
85.72x
5Y Avg
85.72x
Market Cap
$738.17M
Interest Coverage Ratio
-696.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mesa Laboratories, Inc. (MLAB) | $764.65M | 1.73x | 1.94x | 1.23x | 1.45x |
| Attovia Therapeutics, Inc. (ATTO)vs › | $767.30M | N/A | N/A | N/A | N/A |
| Sana Biotechnology, Inc. (SANA)vs › | $776.43M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $752.61M | N/A | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | -5.87x | 6.84x | 6.84x | 3.53x |
| Apnimed, Inc. (APMD)vs › | $785.11M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $789.07M | -1.65x | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $790.46M | N/A | 85.72x | 85.72x | 85.72x |
| Faeth Therapeutics, Inc. (FTH)vs › | $738.17M | -696.50x | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $736.73M | -22.78x | N/A | N/A | N/A |
Interest Coverage
1.7x
Debt/Equity
0.54
Current Ratio
2.07
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 2.98x |
| 2026-03-31 | 1.06x |
| 2025-12-31 | 2.63x |
| 2025-09-30 | 1.65x |
| 2025-06-30 | 1.39x |
| 2025-03-31 | 0.58x |
| 2024-12-31 | 2.03x |
| 2024-09-30 | 1.16x |
| 2024-06-30 | 1.96x |
| 2024-03-31 | -143.69x |
| 2023-12-31 | -0.04x |
| 2023-09-30 | -0.07x |
| 2023-06-30 | -0.63x |
| 2023-03-31 | 0.37x |
| 2022-12-31 | 2.93x |
| 2022-09-30 | 3.29x |
| 2022-06-30 | -4.53x |
| 2022-03-31 | -0.09x |
| 2021-12-31 | -2.47x |
| 2021-09-30 | 5.15x |
| 2021-06-30 | 3.57x |
| 2021-03-31 | 1.93x |
| 2020-12-31 | 0.01x |
| 2020-09-30 | 2.31x |
| 2020-06-30 | 1.86x |
| 2020-03-31 | 0.45x |
| 2019-12-31 | -1.69x |
| 2019-09-30 | 3.36x |
| 2019-06-30 | 13.65x |
| 2018-12-31 | 3.34x |
